Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Increase in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 161,400 shares, a growth of 29.6% from the December 15th total of 124,509 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Ascentage Pharma Group International Price Performance

OTCMKTS:ASPHF opened at $8.48 on Monday. The stock has a 50 day simple moving average of $8.62 and a 200 day simple moving average of $8.46. Ascentage Pharma Group International has a 1-year low of $7.50 and a 1-year high of $10.65.

About Ascentage Pharma Group International

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.